Medtech Acquisition Corp Performance
| MTACUDelisted Stock | USD 9.86 0.00 0.00% |
The company secures a Beta (Market Risk) of -0.042, which conveys not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Medtech Acquisition are expected to decrease at a much lower rate. During the bear market, Medtech Acquisition is likely to outperform the market. Medtech Acquisition Corp right now secures a risk of 0.0%. Please verify Medtech Acquisition Corp mean deviation, treynor ratio, as well as the relationship between the Treynor Ratio and day median price , to decide if Medtech Acquisition Corp will be following its current price movements.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Medtech Acquisition Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable fundamental indicators, Medtech Acquisition is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors. ...more
| Begin Period Cash Flow | 200.9 K | |
| Total Cashflows From Investing Activities | 233.2 M |
Medtech |
Medtech Acquisition Relative Risk vs. Return Landscape
If you would invest 986.00 in Medtech Acquisition Corp on September 19, 2024 and sell it today you would earn a total of 0.00 from holding Medtech Acquisition Corp or generate 0.0% return on investment over 90 days. Medtech Acquisition Corp is currently producing negative expected returns and takes up 0.0% volatility of returns over 90 trading days. Put another way, 0% of traded stocks are less volatile than Medtech, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Medtech Acquisition Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Medtech Acquisition's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Medtech Acquisition Corp, and traders can use it to determine the average amount a Medtech Acquisition's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| MTACU |
Based on monthly moving average Medtech Acquisition is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Medtech Acquisition by adding Medtech Acquisition to a well-diversified portfolio.
Medtech Acquisition Fundamentals Growth
Medtech Stock prices reflect investors' perceptions of the future prospects and financial health of Medtech Acquisition, and Medtech Acquisition fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Medtech Stock performance.
| Return On Asset | -0.0193 | |||
| Current Valuation | 81.09 M | |||
| Price To Earning | 39.61 X | |||
| EBITDA | (8.58 M) | |||
| Cash And Equivalents | 69.18 K | |||
| Total Debt | 2.37 M | |||
| Debt To Equity | 1.77 % | |||
| Book Value Per Share | (2.42) X | |||
| Cash Flow From Operations | (2.74 M) | |||
| Earnings Per Share | 0.26 X | |||
| Total Asset | 20.19 M | |||
| Retained Earnings | (13.27 M) | |||
About Medtech Acquisition Performance
Assessing Medtech Acquisition's fundamental ratios provides investors with valuable insights into Medtech Acquisition's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Medtech Acquisition is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
MedTech Acquisition Corporation does not have significant operations. The company was incorporated in 2020 and is based in Greenwich, Connecticut. Medtech Acquisition is traded on NASDAQ Exchange in the United States.Things to note about Medtech Acquisition Corp performance evaluation
Checking the ongoing alerts about Medtech Acquisition for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Medtech Acquisition Corp help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Medtech Acquisition is not yet fully synchronised with the market data | |
| Medtech Acquisition has a very high chance of going through financial distress in the upcoming years | |
| Medtech Acquisition Corp has accumulated 2.37 M in total debt with debt to equity ratio (D/E) of 1.77, which is about average as compared to similar companies. Medtech Acquisition Corp has a current ratio of 0.15, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Note, when we think about Medtech Acquisition's use of debt, we should always consider it together with its cash and equity. | |
| Medtech Acquisition Corp has accumulated about 69.18 K in cash with (2.74 M) of positive cash flow from operations. |
- Analyzing Medtech Acquisition's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Medtech Acquisition's stock is overvalued or undervalued compared to its peers.
- Examining Medtech Acquisition's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Medtech Acquisition's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Medtech Acquisition's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Medtech Acquisition's stock. These opinions can provide insight into Medtech Acquisition's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Other Consideration for investing in Medtech Stock
If you are still planning to invest in Medtech Acquisition Corp check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Medtech Acquisition's history and understand the potential risks before investing.
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |